MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 3 filers reported holding MARKER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $27 | – | 100 | -50.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 200 | -71.4% | 0.00% | -100.0% |
| Q1 2021 | $2,000 | +100.0% | 700 | +40.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 500 | -58.3% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | 0.0% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -60.0% | 1,200 | -55.6% | 0.00% | -50.0% |
| Q1 2020 | $5,000 | -54.5% | 2,700 | -32.5% | 0.00% | -50.0% |
| Q4 2019 | $11,000 | -31.2% | 4,000 | +29.0% | 0.00% | -42.9% |
| Q3 2019 | $16,000 | -5.9% | 3,100 | +47.6% | 0.01% | -12.5% |
| Q2 2019 | $17,000 | +112.5% | 2,100 | +75.0% | 0.01% | +100.0% |
| Q1 2019 | $8,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |